---
title: "Discussion on \"What risk-proportional validation looks like on a real study\" | Hashnode"
description: "Discussion on \"What risk-proportional validation looks like on a real study\". Our validation page makes a general case: validate the artifact and not the author, and let the rigor scale with the risk the output carries. That is easy to agree with in the abstract and harder to r"
url: "https://hashnode.com/posts/what-risk-proportional-validation-looks-like-on-a-real-study/6af53e9077a2aa1919597797"
---

[Feed](https://hashnode.com/feed) /

Discussion

# [What risk-proportional validation looks like on a real study](https://techworkslab.hashnode.dev/what-risk-proportional-validation-looks-like-on-a-real-study?utm_source=hashnode&utm_medium=feed)

Our validation page makes a general case: validate the artifact and not the author, and let the rigor scale with the risk the output carries. That is easy to agree with in the abstract and harder to r

Nov 12 · 5 min read · techworkslab.hashnode.dev  
Read the article

-   [#clinical-trials](https://hashnode.com/tag/clinical-trials)

## Written by

[TECHWORKSLAB](https://hashnode.com/@techworkslab)

@techworkslab

  
[View profile](https://hashnode.com/@techworkslab)

## Responses

Markdown supported · ⌘↵ to post

No responses yet.
